Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ SLC27A3 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA566931

Catalog No. PIPA566931


Only null left
Add to Cart

Description

Description

Immunogen sequence: DTWERFVRRFG PLQVLETYGL TEGNVATINY TGQRGAVGRA SWLYKHIFPF SLIRYDVTTG EPIRDPQGHC MATSPGEPGL LVAPVSQQSP FLGYAGGPEL AQGKLLKDVF R Highest antigen sequence identity to the following orthologs - mouse 88%, rat 89%.

SLC27A3 has acyl-CoA ligase activity for long-chain and very-long-chain fatty acids.SLC27A3 does not exhibit fatty acid transport activity.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SLC27A3
Polyclonal
Unconjugated
SLC27A3
Acsvl3; FATP3; FATP-3; fatty acid transport protein 3; long-chain fatty acid transport protein 3; mFLJ00207 protein; PSEC0067; Slc27a3; solute carrier family 27 (fatty acid transporter), member 3; solute carrier family 27 member 3; UNQ367/PRO703; Very long-chain acyl-CoA synthetase homolog 3; VLCS-3
Rabbit
Antigen affinity chromatography
RUO
11000
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Immunocytochemistry
0.8 mg/mL
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
Q5K4L6
SLC27A3
Recombinant Human SLC27A3. Recombinant protein control fragment (Product #RP-107584).
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.